Update pfizer
This commit is contained in:
parent
6dbde3652f
commit
361bc4a87e
|
@ -72,7 +72,7 @@
|
|||
|
||||
![Pfizer-BioNTech and AstraZeneca, Oxford Vaccine effectiveness in over 70s](../graphs/msedge_wHYBNSH4e2.jpg)
|
||||
|
||||
[Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England
|
||||
* [Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England
|
||||
* [The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine](https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_w) — CDC, 18 Décembre 2020
|
||||
|
||||
### Israël
|
||||
|
@ -83,8 +83,13 @@
|
|||
|
||||
Le vaccin Pfizer montre une bonne efficacité contre les variants B.1.1.7 (dit "anglais") et B.1.351 (dit "africain")
|
||||
|
||||
* [Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants](https://www.nejm.org/doi/10.1056/NEJMc2104974) — NEJM, 5 Mai 2021
|
||||
* [BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans](https://www.nature.com/articles/s41586-021-03653-6) — Nature, 27 Mai 2021
|
||||
|
||||
## Autres études
|
||||
|
||||
* [BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting](https://www.nejm.org/doi/full/10.1056/NEJMoa2101765) — NEJM, 15 Avril 2021
|
||||
|
||||
## Autorisations et recommandations
|
||||
|
||||
| Pays / Zone | Document(s) |
|
||||
|
|
Loading…
Reference in a new issue